Free Trial

Phio Pharmaceuticals (PHIO) Insider Trading & Ownership

Phio Pharmaceuticals logo
$2.53 +0.15 (+6.30%)
(As of 11/21/2024 ET)

Phio Pharmaceuticals (NASDAQ:PHIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.59%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$3,017.88
Number Of
Insiders Selling
(Last 12 Months)
0
Get PHIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Phio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PHIO Insider Buying and Selling by Quarter

Phio Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/6/2024Robert J BittermanCEOBuy111$6.75$749.25  
2/26/2024Robert J BittermanCEOBuy277$8.19$2,268.63  
(Data available from 1/1/2013 forward)

PHIO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Phio Pharmaceuticals includes Robert J Bitterman, and Robert L Ferrara. Learn more on insiders at PHIO.

0.59% of Phio Pharmaceuticals stock is owned by insiders. Learn more on PHIO's insider holdings.

The following insiders have purchased PHIO shares in the last 24 months: Robert J Bitterman ($8,583.30), and Robert L Ferrara ($7,012.98).

Insiders have purchased a total of 1,687 PHIO shares in the last 24 months for a total of $15,596.28 bought.

Phio Pharmaceuticals Key Executives

  • Mr. Robert J. Bitterman (Age 73)
    President, CEO & Chairman
    Compensation: $380.25k
    1 recent trades
  • Mr. Robert M. Infarinato CPA (Age 78)
    Esq., CFO & Principal Accounting Officer
  • Ms. Linda M. Mahoney
    Senior Vice President of Development
  • Ms. Caitlin Kontulis (Age 38)
    Secretary


This page (NASDAQ:PHIO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners